Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Lack of funds
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
All patients with chronic kidney disease (stages 3, 4 and 5) and chronic dialysis patients with HCV infection attending nephrology and Hepatology OPD or getting outpatient dialysis at the dialysis unit of ILBS.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| advanced chronic kidney disease | Subjects on dialysis with GFR (Glomerular Filtration Rate) > 30 | ||
| Renal replacement therapy. | Subjects who are not on dialysis with GFR (Glomerular Filtration Rate) < 15 |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Sustained Virologic Response 24 defined as HCV RNA <Lower Level of Qunatification 24 weeks after discontinuation of therapy. | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| number of adverse Events in both groups | 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients with chronic kidney disease (stages 3, 4 and 5) and chronic dialysis patients with Hepatitis C infection attending nephrology and Hepatology OPD (Out Patient Department) or getting outpatient dialysis at the dialysis unit of Institute of Liver and Biliary Sciences.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dr Suman Lata Nayak, DM | Institute of Liver and Biliary Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institute of liver and Biliary Sciences | New Delhi | National Capital Territory of Delhi | 110070 | India |
Not provided
Not provided
Not provided
Not provided